What Federal Cannabis Rescheduling Means for Care
Cannabis Schedule III rescheduling marks a major shift in how cannabis is classified and understood at the federal level. This change begins to align policy with clinical reality, affecting research, documentation, and patient access. Cannabis Schedule…
Attitudes, beliefs and willingness to prescribe medical cannabis among public medical practitioners in Malaysia.
A nationwide survey of Malaysian physicians reveals measured acceptance of medical cannabis, with 65% supporting availability for certain conditions. The strongest support emerged for pain management applications, where 87% of doctors endorsed medical…
Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis.
A large Canadian observational study demonstrates medical cannabis real world effectiveness across chronic pain, anxiety, and sleep disorders over 24 weeks. This real-world evidence provides clinicians with practical outcome expectations for sustained…
Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.
A large Israeli healthcare study examining medical cannabis prescribing patterns autism children found only 1.2% of autistic individuals received prescriptions, but concerning pediatric use patterns suggest need for stricter clinical oversight and…
Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review.
A rapid review of 15 studies examining higher THC medicinal cannabis efficacy found therapeutic benefits for chronic pain and PTSD. The review also confirmed increased risk of cognitive and psychiatric adverse effects. This evidence provides important…
Medical marijuana for management of cancer pain: a narrative review.
A 2025 narrative review examines medical marijuana cancer pain management across 20 recent studies. It highlights ongoing knowledge gaps despite expanding legal access. The review consolidates current research trends on medical marijuana cancer pain…
Effects of Prescribed Medical Cannabis on Driving: Study Protocol Analysis
Australian researchers have developed a medical cannabis driving safety protocol to assess real-world driving performance in patients using prescribed THC. This two-phase trial aims to provide critical evidence on driving safety for medical cannabis…
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review
This systematic review highlights cannabinoids diabetic neuropathy pain relief, showing significant benefits in three of four trials. THC-containing products demonstrated the strongest efficacy for diabetic nerve pain. These findings provide…
Understanding President Trump’s Executive Order on Medical Cannabis Rescheduling
The federal medical marijuana rescheduling update under President Trump’s executive order aims to remove barriers to research, prescribing, and insurance coverage. This change would enable standardized treatment guidelines and evidence-based dosing…
President Trump’s Administration Reclassifies State-Licensed Medical Marijuana as Lower-Risk Drug
The state-licensed medical marijuana reclassified as lower-risk drug marks a significant policy shift by the Trump administration. This change may reduce regulatory barriers and expand research opportunities. Clinicians should monitor its impact on…